U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Tirzepatide Injection
Status: Currently in Shortage
»Date first posted: 12/15/2022
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Eli Lilly and Co. (Reverified 07/16/2024)

Company Contact Information:
800-545-5979

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Mounjaro, Injection, 5 mg/.5 mL (NDC 0002-1495-80) Available
Mounjaro, Injection, 10 mg/.5 mL (NDC 0002-1471-80) Limited Availability Limited availability through July 2024. Demand increase for the drug
Mounjaro, Injection, 2.5 mg/.5 mL (NDC 0002-1506-80) Available
Mounjaro, Injection, 7.5 mg/.5 mL (NDC 0002-1484-80) Available
Mounjaro, Injection, 12.5 mg/.5 mL (NDC 0002-1460-80) Available
Mounjaro, Injection, 15 mg/.5 mL (NDC 0002-1457-80) Limited Availability Limited availability through July 2024. Demand increase for the drug
Zepbound, Injection, 5 mg/.5 mL (NDC 0002-2495-80) Available
Zepbound, Injection, 12.5 mg/.5 mL (NDC 0002-2460-80) Available
Zepbound, Injection, 2.5 mg/.5 mL (NDC 0002-2506-80) Available
Zepbound, Injection, 7.5 mg/.5 mL (NDC 0002-2484-80) Available
Zepbound, Injection, 10 mg/.5 mL (NDC 0002-2471-80) Limited Availability Limited availability through July 2024. Demand increase for the drug
Zepbound, Injection, 15 mg/.5 mL (NDC 0002-2457-80) Limited Availability Limited availability through July 2024. Demand increase for the drug
Back to Top